Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
HIV Medicine|April 28, 2007
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsV Le Moing, R Thiébaut, G Chêne, et al.
The Journal of Infectious Diseases|July 29, 2000
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patientsJ M Molina, F Ferchal, C Rancinan, et al.
Diabetes & Metabolism|March 14, 2019
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patientsJ-P Bastard, C Couffignal, S Fellahi, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2018
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohortA Provoost, M Dramé, L Cotte, et al.
HIV Medicine|August 24, 2006
Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO studyV Reliquet, C Allavena, C François-Brunet, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Circulation. Cardiovascular Quality and Outcomes|April 22, 2025
Computational Phenomapping of Randomized Clinical Trial Participants to Enable Assessment of Their Real-World Representativeness and Personalized InferencePhyllis M Thangaraj, Evangelos K Oikonomou, Lovedeep S Dhingra, et al.
JAMA Network Open|June 7, 2023
Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020Lovedeep S Dhingra, Arya Aminorroaya, Evangelos K Oikonomou, et al.
The Journal of Infection|January 9, 2007
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study)B Amellal, C Allavena, E André-Garnier, et al.
Medecine Et Maladies Infectieuses|June 28, 2011
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic]C Biron, O Beaudoux, A Ponge, et al.
Pageof 30